Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

Under a new proposal, people in England will be able to pay the NHS to have their genome sequenced, as long as they agree to share their anonymised data with researchers. This scheme would work in parallel with NHS-funded genome sequencing offered to people with certain inherited conditions and follows the 100,000 Genomes Project, which set out to learn more about how changes in DNA contribute to rare diseases and cancer.

Collecting genome sequence data from healthy people will undoubtedly increase our understanding of the link between DNA and disease and lead to new treatments. However, NHS delivery of a service that lets the public pay for personalised reports on their genetic make-up is premature.

Read the full article on The Conversation website, written by Elizabeth Ormondroyd, Genetic Counsellor / Researcher, Radcliffe Department of Medicine. 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19

Clinical Trials Coronavirus COVID-19 General Research

The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.

Ancient gene mutation found to cause rare hereditary condition

General Research

UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).